# The mouse gastric surface epithelial cell and its response to early Helicobacter pylori infection

**Authors:** Mattias Erhardsson, Licínia Santos, John Benktander, Sinan Sharba, Kaisa Thorell, Sara Lindén

PMC · DOI: 10.1080/21505594.2026.2645859 · Virulence · 2026-03-13

## TL;DR

This study explores how mouse stomach cells respond to early Helicobacter pylori infection, revealing changes in gene activity and mucus structure that could help improve treatments.

## Contribution

The study provides a detailed characterization of gene expression and glycosylation in gastric surface epithelial cells during early H. pylori infection.

## Key findings

- SMC gene expression includes proteins secreted into mucus and cytoskeleton proteins.
- Mucin glycans are large, complex, and heavily fucosylated with H-antigen motifs.
- H. pylori infection down-regulates protein synthesis and oxidative phosphorylation genes.

## Abstract

Helicobacter pylori infection is the main risk factor for gastric cancer. H. pylori easily develop antibiotic resistance and evade host defenses. In-depth knowledge of the first barrier that H. pylori encounter, the gastric surface mucus-producing epithelial cells (SMCs), may enable improved treatment and prevention. This study aimed to characterize SMC gene expression, mucus glycosylation, and identify how H. pylori colonization affects these parameters. The glycosylation of eight H. pylori-infected and eight sham control mice was characterized by mass spectrometry. SMCs from five infected and five sham control mice were extracted with laser microdissection (LCM) and sequenced with RNA sequencing (RNA-Seq). SMCs were characterized by high gene expression for proteins secreted into mucus (Tff1, Gkn1, Gkn2, Psca, and Muc5ac), mitoribosome RNA, and cytoskeleton proteins. Mucin glycans were large, complex, heavily fucosylated, and dense with H-antigen motifs. Two main glycosylation pathways ending in H-antigen glycans were identified and corroborated with glycosyltransferase expression. Glycosylation was consistent between H. pylori-infected and sham control mice. RNA-Seq data was analysed for differential gene expression, gene set enrichment analysis, and network analysis of functionally-related genes. The analyses revealed that genes required for protein synthesis and oxidative phosphorylation were down-regulated in infected mice. Most up-regulated genes were either interferon-stimulated genes or able to induce interferon production themselves. Depletion of Nkx6-3 occurred in the infected mice, indicating initiation of a pre-cancerous cascade. LCM RNA-Seq of SMCs was thus feasible and enabled characterization of the SMC and definition of a gene set showing how H. pylori infection affects SMCs.

## Linked entities

- **Genes:** TFF1 (trefoil factor 1) [NCBI Gene 7031], GKN1 (gastrokine 1) [NCBI Gene 56287], GKN2 (gastrokine 2) [NCBI Gene 200504], PSCA (prostate stem cell antigen) [NCBI Gene 8000], MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586], NKX6-3 (NK6 homeobox 3) [NCBI Gene 157848]
- **Diseases:** gastric cancer (MONDO:0001056)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CBLIF (cobalamin binding intrinsic factor) [NCBI Gene 2694] {aka GIF, IF, IFMH, INF, TCN3}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, VacA [NCBI Gene 48201093], TFF2 (trefoil factor 2) [NCBI Gene 7032] {aka SML1, SP}, KRT16 (keratin 16) [NCBI Gene 3868] {aka CK16, FNEPPK, K16, K1CP, KRT16A, NEPPK}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, Mucin [NCBI Gene 100508689], COX1 (cytochrome c oxidase subunit I) [NCBI Gene 17708] {aka CoxI}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, COX6C (cytochrome c oxidase subunit 6C) [NCBI Gene 1345], Gkn1 (gastrokine 1) [NCBI Gene 66283] {aka 2200002K21Rik, AMP-18, BRICD1, Fov}, Tff1 (trefoil factor 1) [NCBI Gene 21784] {aka Bcei, PS2}, Krt8 (keratin 8) [NCBI Gene 16691] {aka Card2, EndoA, K8, Krt-2.8, Krt2-8, TROMA-1}, B3gnt3 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3) [NCBI Gene 72297] {aka 2210008L19Rik}, Krt19 (keratin 19) [NCBI Gene 16669] {aka CK-19, EndoC, K19, Krt-1.19, Krt1-19}, RN7SK (RNA component of 7SK nuclear ribonucleoprotein) [NCBI Gene 125050] {aka 7SK}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, ST2 (suppression of tumorigenicity 2) [NCBI Gene 6761], FCGBP (Fc gamma binding protein) [NCBI Gene 8857] {aka FC(GAMMA)BP}, Clec3b (C-type lectin domain family 3, member b) [NCBI Gene 21922] {aka Tna}, ATP6V1D (ATPase H+ transporting V1 subunit D) [NCBI Gene 51382] {aka ATP6M, VATD, VMA8}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, S100A8 (S100 calcium binding protein A8) [NCBI Gene 6279] {aka 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag}, CagA [NCBI Gene 48200769], HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) [NCBI Gene 57531] {aka SPPRS}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, Fut2 (fucosyltransferase 2) [NCBI Gene 14344] {aka MFUT-II}, TLR8 (toll like receptor 8) [NCBI Gene 51311] {aka CD288, IMD98, TLR-8, hTLR8}, Xdh (xanthine dehydrogenase) [NCBI Gene 22436] {aka XO, Xor, Xox-1, Xox1}, Cp (ceruloplasmin) [NCBI Gene 12870] {aka D3Ertd555e}, PTGER4 (prostaglandin E receptor 4) [NCBI Gene 5734] {aka EP4, EP4R}, Atp4a (ATPase, H+/K+ exchanging, gastric, alpha polypeptide) [NCBI Gene 11944], mt-Rnr1 (s-rRNA) [NCBI Gene 17724], Mal (myelin and lymphocyte protein, T cell differentiation protein) [NCBI Gene 17153] {aka Mpv17, Vip17}, ITGAX (integrin subunit alpha X) [NCBI Gene 3687] {aka CD11C, SLEB6}, LGALS3BP (galectin 3 binding protein) [NCBI Gene 3959] {aka 90K, BTBD17B, CyCAP, M2BP, MAC-2-BP, TANGO10B}, ATP6 (ATP synthase F0 subunit 6) [NCBI Gene 17705], Xrn2 (5'-3' exoribonuclease 2) [NCBI Gene 24128], NCR2 (natural cytotoxicity triggering receptor 2) [NCBI Gene 9436] {aka CD336, LY95, NK-p44, NKP44, dJ149M18.1}, GKN1 (gastrokine 1) [NCBI Gene 56287] {aka AMP18, BRICD1, CA11, FOV, foveolin}, Srp54a (signal recognition particle 54A) [NCBI Gene 24067] {aka 54kDa, Srp54}, DYM (dymeclin) [NCBI Gene 54808] {aka DMC, SMC}, PSCA (prostate stem cell antigen) [NCBI Gene 8000] {aka PRO232, lncPSCA}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, ND6 (NADH dehydrogenase subunit 6) [NCBI Gene 17722], Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, S100a13 (S100 calcium binding protein A13) [NCBI Gene 20196], Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Muc6 (mucin 6, gastric) [NCBI Gene 353328], Iigp1 (interferon inducible GTPase 1) [NCBI Gene 60440] {aka 2900074L10Rik, Ifgga1, Iigp, Irga6}, MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586] {aka MUC5, TBM, leB, mucin}, Lgals2 (lectin, galactose-binding, soluble 2) [NCBI Gene 107753] {aka 2200008F12Rik}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Ly6 (lymphocyte antigen 6 complex) [NCBI Gene 17062] {aka Ala-1, DAG, H9/25, Ly-27, Ly-6, Ly27}, YAM1 (YY1-associated myogenesis RNA 1) [NCBI Gene 107161157] {aka Yam-1}, RPL19 (ribosomal protein L19) [NCBI Gene 6143] {aka L19, eL19}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, Tspan8 (tetraspanin 8) [NCBI Gene 216350] {aka E330007O21Rik, Tm4sf3}, mt-Rnr2 (16S ribosomal RNA) [NCBI Gene 17725]
- **Diseases:** death and (MESH:D003643), carcinogenesis (MESH:D063646), non-alcoholic fatty liver disease (MESH:D065626), long-term infection (MESH:D000088562), Infected (MESH:D007239), Chronic gastritis (MESH:D005756), gastrointestinal (MESH:D005767), SS1 (MESH:D012507), gastric adenocarcinoma (MESH:D013274), MALT lymphoma (MESH:D018442), SPEM (MESH:D008679), gastro-duodenal ulcers (MESH:D004381), inflamed (MESH:C531841), UMAP (MESH:C567162), cancer (MESH:D009369), weight loss (MESH:D015431), dislocation (MESH:D004204), Inflammation (MESH:D007249), carcinogenic (MESH:D011230), coronavirus disease - COVID-19 (MESH:D000086382), H. pylori (MESH:D016481), ISGs (MESH:C535530)
- **Chemicals:** Fucose (MESH:D005643), ethanol (MESH:D000431), Alexa Fluor  594 (-), H (MESH:D006859), citric acid (MESH:D019343), agar (MESH:D000362), Galactose (MESH:D005690), xylene (MESH:D014992), Glycan (MESH:D011134), glycerol (MESH:D005990), monosaccharides (MESH:D009005), Eosin (MESH:D004801), DAPI (MESH:C007293), sodium dodecyl sulfate (MESH:D012967), GlcNAc (MESH:D000117), Tn (MESH:C009497), H&amp;E (MESH:D006371), ROS (MESH:D017382), paraffin (MESH:D010232), N-Acetylgalactosamine (MESH:D000116), isoflurane (MESH:D007530), Formalin (MESH:D005557), PEN (MESH:C058388), urea (MESH:D014508), NaCl (MESH:D012965), Gal (MESH:C101993), water (MESH:D014867), aluminum (MESH:D000535), Cresyl Violet (MESH:C028911), isopropanol (MESH:D019840), Tween 20 (MESH:D011136), Hematoxylin (MESH:D006416), formamide (MESH:C031066)
- **Species:** Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090], Macaca mulatta (rhesus macaque, species) [taxon 9544], Citrobacter rodentium (species) [taxon 67825], Homo sapiens (human, species) [taxon 9606], Helicobacter pylori SS1 (strain) [taxon 102617], Brucella (genus) [taxon 234], Helicobacter pylori (species) [taxon 210]
- **Cell lines:** Balb — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0637), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13020875/full.md

## Figures

33 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13020875/full.md

## References

189 references — full list in the complete paper: https://tomesphere.com/paper/PMC13020875/full.md

---
Source: https://tomesphere.com/paper/PMC13020875